Brazil likely to get Oxford’s COVID-19 vaccine by year end: Drug maker AstraZeneca


Sao Paulo: Drug maker AstraZeneca said Brazil may get Oxford’s coronavirus vaccine by end of the year if trials will become successful.

The vaccine is being tested on more than 5,000 health care workers in Brazil since last week. It may be noted that on 2nd June, Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials being conducted in partnership with AstraZeneca.

Apart from Oxford, China National Biotec Group (CNBG) has also started phase 3 clinical trials of its inactivated COVID-19 vaccine candidate in the United Arab Emirates.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.